Processing
Processing. Please wait...

Algae insider: Ward Marlatte

 
 All Insiders  
 
Summary
PerformanceFundamentalsTechnicalsRecomendation
   Summary
   History
   Headlines
   Leaders
   Widgets

CEO, Secretary, Director

We currently do not have informatin regarding Ward Marlatte. This executive tanure with Algae Biosciences Corporation is not currenlty determined.
  CEO Since 2013      
928-240-1060  http://www.algaebio.com

Other Appointments

Algae Biosciences CorporationAGBCFUnited States OTCCEO
ALGAE BIOSCIENCES CORPORATIONABVCanada TSXVCEO

Management Efficency

The company has return on total asset (ROA) of (21.6) % which means that it has lost $21.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (51.33) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 477.23 K in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Algae Biosciences Corporation has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Entity Summary

Ward Marlatte, Chief Exec. Officer, Sec. and DirectorN/AN/AMr. Marc Joseph Stachiw, Interim Chief Financial Officer and DirectorN/AN/AMr. Anthony H. Smith, 46Exec.N/A0.00 Wayne M. Tinker, Exec.N/A0.00Algae Biosciences Corporation [AGBCF] is traded on OTC Market in USA. It is located in , except where noted. and employs 5 people.

Filter other executives

Tenure
Industry  
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 

Showing few of many executives

CEO Since

Soeren SkouAP M
2012
Nils AndersenAP M
2012
Timothy MayopoulosFederal National Mortgage Assoc
2012
Timothy MayopoulosFED NATL MTG PFD I
2012
Morten EngelstoftAP M
2014
Tsahi CohenBK HAPOALIM
2012
Allan ObermanTEVA PHARMA IND
2012
Chung Chul-KhilSK Innovation
N/A
Erez VigodmanTEVA PHARMA IND
2014
Avraham KochvaBK HAPOALIM
2014
Ron WekslerBK HAPOALIM
2013
Kim FejferAP M
2011
Carlo NotaristefaniTEVA PHARMA IND
2012
Ari PintoBK HAPOALIM
2013
Eliyahu CohenBK HAPOALIM
2011
Anat LevinBK HAPOALIM
2010
Claus HemmingsenAP M
2007
Robert KoremansTEVA PHARMA IND
2013
Shimon GalBK HAPOALIM
2013
Judith VardiTEVA PHARMA IND
2012
Zeev HayoBK HAPOALIM
2014
SymbolAGBCF
NameAlgae Biosciences Corporation
InstrumentUSA Stock
Risk-adjusted AdviceStrong Sell Fairly Valued
CurrencyUSD - US Dollar
ExchangeOTC Market
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Algae Biosciences Corporation to your portfolio

Algae Biosciences Leadership

Laurence Luke, Director
Kevin Blanchette, Director
Jody Stachiw, Director
Ward Marlatte, CEO
Marc Stachiw, Director
Gordon Aldcorn, Director

Stock Performance

Shares Outstanding71.76 M